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Abstract
Background: In humans it is unknown if the composition of the gut microbiota alters the risk of Plasmodium
falciparum infection or the risk of developing febrile malaria once P. falciparum infection is established. Here we
collected stool samples from a cohort composed of 195 Malian children and adults just prior to an intense P. falciparum
transmission season. We assayed these samples using massively parallel sequencing of the 16S ribosomal RNA gene to
identify the composition of the gut bacterial communities in these individuals. During the ensuing 6-month P. falciparum
transmission season we examined the relationship between the stool microbiota composition of individuals in this cohort
and their prospective risk of both P. falciparum infection and febrile malaria.
Results: Consistent with prior studies, stool microbial diversity in the present cohort increased with age, although the
overall microbiota profile was distinct from cohorts in other regions of Africa, Asia and North America. Age-adjusted
Cox regression analysis revealed a significant association between microbiota composition and the prospective risk of
P. falciparum infection; however, no relationship was observed between microbiota composition and the risk of
developing febrile malaria once P. falciparum infection was established.
Conclusions: These findings underscore the diversity of gut microbiota across geographic regions, and suggest that
strategic modulation of gut microbiota composition could decrease the risk of P. falciparum infection in malaria-endemic
areas, potentially as an adjunct to partially effective malaria vaccines.
Keywords: Stool microbiota, Gut microbiota, Malaria, 16S rRNA gene sequencing, Plasmodium falciparum, Human,
Prospective cohort
Background
The human microbiome represents the trillions of mi-
crobes that naturally inhabit the human body, the vast
majority of which reside within the gastrointestinal tract
[1]. Major advances in sequencing technology have
allowed for investigations of the microbiome in the con-
text of health and disease. Large-scale studies of the west-
ernized human microbiome, including the NIH funded
Roadmap Human Microbiome Project (HMP) [2, 3]
targeting several body sites and the European Commission
funded Metagenomics of the Human Intestinal Tract [4],
have defined the healthy human microbiome, providing a
reference for subsequent studies into the interactions be-
tween microbes and their environment in the context of
host immunity and/or genetics.
Systematic studies aimed at understanding the com-
plex interactions between the host and microbiota have
demonstrated that the composition of the gut micro-
biota varies with age [5–7], race/ethnicity [2], geograph-
ical location [5, 6], and dietary intake [7–9]. The role of
the microbiota in modulating host immune responses to
infectious pathogens is also increasingly recognized [10].
Indeed, the composition of the gut microbiota has been
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shown to influence both local [11–13] and systemic
[14–16] immune responses.
Among parasitic pathogens, Plasmodium falciparum
malaria, which is transmitted by Anopheles mosquitos,
imposes the greatest disease burden worldwide. The
World Health Organization (WHO) estimates that 3.3
billion people are at risk of malaria in 97 countries. In
2013, there were approximately 198 million cases of
malaria and an estimated 584,000 deaths, 90 % of which
occurred in Africa, with children under 5 years account-
ing for 78 % of all deaths [17].
In areas of intense malaria transmission, immunity to
life-threatening malaria is typically acquired by early
childhood, whereas older children remain susceptible to
repeated bouts of febrile malaria through adolescence,
eventually acquiring near-complete immunity to the dis-
ease caused by blood-stage malaria parasites by early
adulthood [18, 19]. However, despite repeated infections
over years, sterilizing acquired immunity to P. falcip-
arum infection seems to occur rarely [20]. The nature of
the human immune response that protects from P. falcip-
arum infection and the disease it causes is complex and
only partially understood [21]. Indeed, the quality of the im-
mune response and the clinical outcome during any given
P. falciparum infection can vary greatly between and within
individuals [22]. Although host and parasite genetic factors
[23, 24] clearly contribute to the heterogeneity in immune
and clinical responses to malaria, it is likely that environ-
mental factors such as the host microbiota also play a role.
For example, a recent mouse study demonstrated that
anti-α-gal antibodies—induced by the presence of
Escherichia coliO86:B7 in the gut—are cytotoxic to α-
gal-expressing Plasmodium sporozoites, and thus protect
mice from mosquito-transmitted Plasmodium infection
[25]. In the same report, an association was observed be-
tween anti-α gal IgM levels and protection from P. falcip-
arum infection in Malian children and adults residing in
an area of intense malaria transmission [25], suggesting
that the host microbiota may play a role in susceptibility
to P. falciparum infection in humans. In addition, Li et al.
[26] noted that experimental infection of mice with Plas-
modium berghei resulted in altered metabolite profiles that
they attributed to a disturbance of the gut microbial com-
munity caused by the parasite. However, it is currently un-
known in humans if the composition of the gut microbiota
modulates the risk of P. falciparum infection or the risk of
developing malarial disease once P. falciparum blood-stage
infection is established.
To investigate the potential interplay between P. fal-
ciparum and the gut microbiota, we analyzed the bacter-
ial communities in stool samples collected from a cohort
of 195 Malian children and adults just prior to an in-
tense malaria transmission season. Community compos-
ition was determined by sequencing the 16S ribosomal
RNA (rRNA) gene using high-throughput next generation
sequencing technology. In a prospective cohort study we
examined the relationship between the gut microbiota
composition of these individuals and their subsequent risk
of P. falciparum infection and febrile malaria. We also
compared the microbiota composition of this cohort with
published studies conducted in other regions. Consistent
with prior studies, we found that gut microbial diversity in
this cohort increased with age, although the overall micro-
biota profile was distinct from cohorts in other regions of
Africa, Asia and North America. Age-adjusted Cox regres-
sion analysis revealed a significant association between the
microbiota composition before the malaria season and the
prospective risk of P. falciparum infection during the en-
suing malaria season, while no relationship was observed
between microbiota composition and the risk of develop-
ing febrile malaria once P. falciparum infection was
established.
Results
Characteristics of study subjects
From May 11 – May 31, 2011 (end of 6-month dry season)
we enrolled 695 healthy individuals in this cohort study.
Stool was collected from all subjects at the time of enroll-
ment. A subset of 200 individuals was randomly selected in
an age-stratified manner for stool microbiota analysis
(Fig. 1). Of these 200 subjects, 55 subjects (28 %) were
asymptomatically infected with P. falciparum blood-stage
parasites by PCR at enrollment when stool was also col-
lected. The prevalence of intestinal helminths at enrollment
was near zero, consistent with the mass-drug treatment
program in this region of Mali, whereas the prevalence of
Schistosoma haematobium in the urine was 7.4 %, mostly
among adolescents and adults. The prevalence of sickle cell
trait (HbAS) was 8.5 %. Detailed demographic and clinical
data stratified by age are shown in Table 1. Consistent with
our findings in the entire cohort [20], longitudinal analysis
during the ensuing malaria season showed that the risk of
febrile malaria decreased with increasing age in the subset
of individuals in this study, with the exception of infants
under the age of 1 year whose risk was intermediate be-
tween children and adults (Table 2), presumably due to the
protective effect of maternal antibodies [27].
Diversity and composition of the microbiota in Mali stool
samples
Sequence data were successfully generated from 195 out
of the 200 stool samples. After processing the raw se-
quence data, the combined dataset consisted of 1,331,167
sequences. However, not all sequences could be confi-
dently assigned taxonomy to the genus level; therefore we
denote these sequences by appending the tag unclassified
to the end of their taxonomic assignment (one of phylum,
class, order, or family levels). The taxonomic assignments
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were used to generate a sample-taxa count matrix. In the
combined dataset, Bifidobacterium, Streptococcus, and
family Ruminococcaceae unclassified were the three most
abundant taxonomic groups, accounting for 13.7 %,
12.9 %, and 12.4 % of sequences, respectively.
Operational Taxonomic Units (OTUs) were identified
in these data by clustering sequences at 97 % sequence
identity, and were used to compute microbial commu-
nity diversity (alpha diversity) in these samples. Subse-
quently, the relationship between diversity and age was
assessed using a linear model. This analysis revealed that
diversity increased with age in this cohort (Fig. 2); a
similar trend was observed for both genders separately
(Additional file 1: Figure S1).
The sample-taxa count matrix was further analyzed
using a Dirichlet Multinomial Mixture (DMM) modeling
framework [28] to identify sample groups (or Dirichlet
components). An evaluation of the model fit (Additional
file 1: Figure S2) revealed that two Dirichlet components
(hereafter referred to as DC1 and DC2) provided the
best fit for these data. Figure 3 shows a two-dimensional
ordination of these samples that was generated using
non-metric multidimensional scaling (NMDS) based on
Bray-Curtis dissimilarity between samples. The individ-
uals comprising the sample groups DC1 (n = 133) and
DC2 (n = 62) were significantly different in terms of age
(P < 10−15; assessed using a t-test) and taxonomic pro-
files (P ≤ 0.05; assessed by non-overlapping 95 % credible
intervals), but had similar gender distributions. Specific-
ally, the average ages of individuals in DC1 and DC2
were 10.3 years and 1.3 years, respectively. The most
abundant taxa in the older DC1 group were family
Ruminococcaceae unclassified (8.7 %), family Lachnospir-
aceae unclassified (8.5 %), and Faecalibacterium (7.4 %),
while the most abundant taxa in the younger DC2
group were Bifidobacterium (17.1 %) and Streptococcus
(11.6 %) (Fig. 4 and Additional file 1: Table S1).
Comparison of Mali, Malawi, HMP, and MSD cohorts
Next, we compared the gut microbiota composition of the
Mali cohort with data from the Malawi, HMP, and MSD
microbiome studies described in Material and Methods.
The four datasets were analyzed based on taxonomies of
their constituent samples. DMM modeling identified 9
Dirichlet components (CC1 – CC9) (Additional file 1:
Table S2), each with a different taxonomic profile
(Additional file 1: Table S3). The 9 Dirichlet sample
groups largely fell along cohort lines (Additional file 1:
Table S4). For example, the Dirichlet components DC1
and DC2 that were identified by DMM modeling of the
Mali cohort were largely preserved as components CC2
and CC5, respectively. Like CC5, which was comprised
exclusively of Mali samples, CC6 had a high abundance
of Bifidobacterium and Streptococcus, but only contained
samples from the Malawi cohort; however, the proportions
of Bifidobacterium and Streptococcus were different in CC6
(22 % and 5 %, respectively) compared to CC5 (15 % and
11 %, respectively). The HMP samples were predominantly
split across CC4 and CC9, both of which were dominated
by Bacteroides, but at different abundance levels (25 % and
60 %, respectively). The MSD cohort was mostly split
across CC1, CC3, and CC8, all of which were dominated
by Prevotella to varying degrees (8 % in CC1 and 70 %
in CC3) and family Enterobacteriaceae unclassified
(9.6 % in CC8). CC7 consisted of Malawi samples and
was also dominated by Prevotella (21 %).
Relationship between gut microbiota and persistent
P. falciparum infection, incident P. falciparum infection,
and incident febrile malaria in the Malian cohort
We investigated the relationship between the gut micro-
biota composition and three distinct clinical phenotypes
in the Malian cohort: persistent P. falciparum infection,
incident P. falciparum infection, and incident febrile
malaria. These three phenotypes are described in Fig. 5.
In a cross-sectional analysis at the end of the 6-month
dry season, a period of negligible malaria transmission
[29], we first compared the gut microbiota composition of
individuals with persistent, asymptomatic P. falciparum
Fig. 1 Selection of study subjects for stool microbiota analysis
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blood-stage infection versus uninfected individuals. P. fal-
ciparum infections detected at the end of the 6-month dry
season are generally acquired during the preceding trans-
mission season and persist through the dry season at low
levels without causing symptoms. This analysis was car-
ried out using the DMM framework, but in a supervised
manner with subjects classified as either persistently in-
fected (n = 55) or uninfected (n = 140). An NMDS ordin-
ation of the samples along with their P. falciparum
infection status at the end of the dry season is shown in
Fig. 6. Among the 55 persistently infected subjects we
identified two Dirichlet components PP1 (15 subjects) and
PP2 (40 subjects), with average subject ages of 3.2 years
and 13.6 years, respectively (Additional file 1: Table S5).
Among the 140 uninfected subjects we identified two
components PN1 (56 subjects) and PN2 (84 subjects) with
average subject ages of 1.3 years and 9.2 years, respectively
(Additional file 1: Table S5). The mean vector of taxa pro-
portions for component PP2 (older and infected) is very
close to that of component PN2 (older and uninfected) in-
dicating that these two subject groups have very similar
taxonomic proportions, with no statistically significant dif-
ferences (Fig. 7, Additional file 1: Table S6). The mean of
component PP1 (young and infected) was not as close to
the means of either of PN1 or PN2. However, the only
taxa in this component that had a significantly different
proportion compared to its values in PN1 and PN2 was
Bifidobacterium (3.6 %). Together, these findings suggest
that age may be a stronger predictor of gut microbiota
composition than P. falciparum infection status at the end
of the 6-month dry season (i.e. persistent P. falciparum in-
fection versus no infection).
Next, we examined the relationship between the stool
microbiota composition present before the malaria season
and the prospective risk of becoming infected with P. fal-
ciparum blood-stage parasites during the ensuing 6-month
malaria season. For this analysis we only included subjects
who were not infected with P. falciparum (by PCR) before
Table 1 Baseline characteristics of study subjects by age group













Female gender 11 (42 %) 26 (63 %) 16 (43 %) 23 (52 %) 11 (46 %) 19 (68 %) 106 (53 %)








0 0 0 0 1 (4.2 %) 0 1 (0.5 %)
Stool PCR for intestinal helminths
(number positive/number tested)
A. duodenale 0/15 0/24 0/28 0/67
A. lumbricoides 0/11 0/24 0/28 0/63
N. americanus 0/22 0/24 1/28 (3.6 %) 1/74 (1.4 %)
S. stercoralis 0/11 0/24 0/28 0/63
T. trichura 0/11 0/24 0/28 0/63
Kato-Katz for intestinal and urinary helminths
(number positive/number tested)
S. mansoni (stool) 0/24 0/40 0/37 0/44 0/24 0/28 0/197
H. nana (stool) 0/24 0/40 0/37 0/44 0/24 0/28 0/197
S.haematobium
(urine)
2/19 (11 %) 1/39 (2.6 %) 0/37 (0 %) 1/43 (2.3 %) 2/16 (12 %) 7/22 (32 %) 13/176 (7.4 %)
Hb type
AA 23 (88 %) 35 (85 %) 29 (78 %) 38 (86 %) 22 (92 %) 19 (68 %) 166 (83 %)
AC 1 (3.8 %) 3 (7.3 %) 6 (16 %) 2 (4.5 %) 1 (4.2 %) 3 (11 %) 16 (8 %)
AS 2 (7.7 %) 3 (7.3 %) 2 (5.4 %) 4 (9.1 %) 1 (4.2 %) 5 (18 %) 17 (8.5 %)
SC 0 0 0 0 0 1 (3.6 %) 1 (0.5 %)
Hemoglobin,
g/dL (95 % CI)
11.0 (10.7 – 11.3) 10.2 (9.9 – 10.6) 11.1 (10.8 – 11.5) 12.3 (12.0 – 12.6) 13.0 (12.6 – 13.4) 13.5 (12.9 – 14.0) 11.7 (11.5 – 12.0)
aBefore the malaria season and at time of stool collection. All P. falciparum-infected subjects at the time of enrollment were asymptomatic
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Table 2 Malaria outcomes by age group
Outcome Age Group P value
3–5 mo (n = 26) 6 mo–1 y (n = 41) 2–5 y (n = 37) 6–11 y (n = 44) 12–17 y (n = 24) 18–25 y (n = 28)
Median days from enrollment
to first malaria episodea (95 % CI)
227 (159–249) NE 134 (109 – 176) 142 (120 – 257) NE NE <0.0001*
Median parasite density for first















Individuals with ≥1 malaria
episodes (% of age group)
4 (15 %) 5 (12 %) 13 (35 %) 13 (30 %) 1 (4.2 %) 0 <0.001***
Abbreviations: CI, confidence interval; NE, not estimated because >50 % of individuals remained free of malaria during the study period
aMalaria defined as ≥2500 parasites/μL, an axillary temperature of ≥37.5 °C within 24 h, and no other cause of fever discernible by physical exam
*log-rank test
**Kruskal-Wallis test













Fig. 2 Increase in microbial taxa diversity with age in the Malian cohort. For each stool microbiota sample, the alpha diversity (Chao estimate) of
the microbial community (y-axis) was plotted against the individual’s age in years (x-axis). The blue line is the linear model fit and has a positive
slope (P < 10−15)
Fig. 3 An NMDS ordination of the microbiota samples. The taxonomic profiles of the samples were used to compute a sample dissimilarity
matrix (using Bray-Curtis measure) and this matrix was used to compute an ordination of the samples in two dimensions (Axis 1 and Axis 2). The
goodness of fit (or stress) associated with this ordination is 0.197. The circles in this plot denote the samples. The two sample groups (or Dirichlet
components) identified using the mixture modeling are denoted in red (DC1) and blue (DC2). The average ages for the groups are 10.3 years
(DC1) and 1.3 years (DC2). Asterisks denote the vectors of mean taxa proportions associated with the corresponding Dirichlet components
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the malaria season and who had completed study follow-up
through the end of the ensuing 6-month malaria season
(112 subjects). DMM modeling of the microbiota data ob-
tained from these P. falciparum uninfected subjects identi-
fied two Dirichlet components FM1 (38 subjects) and FM2
(74 subjects). These two sample groups had distinct taxo-
nomic profiles (Additional file 1: Table S7, Fig. 8). Bifido-
bacterium (22 %) and Streptococcus (10 %) were the most
abundant taxa in FM1 while family Ruminococcaceae un-
classified (9.3 %), and family Lachnospiraceae unclassified
(9.1 %) were the most abundant taxa in FM2. In addition to
these taxa, other taxa including Faecalibacterium, Blautia,
order Clostridiales unclassified, family Prevotellaceae un-
classified, and Escherichia/Shigella were differentially abun-
dant across the two sample groups (P ≤ 0.05; assessed by
non-overlapping 95 % credible intervals). The average age
of subjects in FM1 and FM2 was 1.4 years and 9.1 years, re-
spectively. During the ensuing malaria season, incident
(new) P. falciparum blood-stage infections in these subjects
were detected through bi-weekly PCR analysis of finger-
prick blood samples. We compared the time to first P. fal-
ciparum infection in the FM1 versus FM2 sample groups
(irrespective of whether the infection caused symptoms) by
generating Kaplan-Meier plots and performing log-rank
analysis (Fig. 9). We noted a statistically significant
delay in time to first P. falciparum infection (Fig. 9a)
for FM1 subjects (median: 121 days; 95 % CI 101–150)
compared to FM2 subjects (median: 85 days; 95 % CI
73–99; P = 0.0002). Moreover, Cox regression analysis
accounting for age, gender, anemia, HbAS, S. haemato-
bium infection, splenomegaly and distance to the river
Fig. 4 Mean proportions (calculated using Maximum Posterior Estimate)
of the twenty most abundant taxa (based on abundance in one of the
groups) in the two Dirichlet components: the older DC1 group (red) and
younger DC2 group (blue). The lower and upper 95 % credible intervals
are shown as error bars
Fig. 5 Definition of persistent P. falciparum infection, incident P. falciparum infection, and incident febrile malaria. This longitudinal cohort study
in Mali was designed to take advantage of the sharply demarcated 6-month malaria season (July – December) and 6-month dry season (January – June)
during which there is either intense or negligible P. falciparum transmission, respectively. Stool microbiota composition was determined for all study
subjects in a cross-sectional survey at the end of the 6-month dry season. For each subject, we examined the relationship between stool microbiota
composition and the risk of persistent P. falciparum infection, incident P. falciparum infection and incident febrile malaria. Individuals with P. falciparum
infections that persisted without symptoms through the dry season were identified by PCR analysis of fingerprick blood samples in a cross-sectional survey
at the end of the 6-month dry season (at the time of stool collection). For subjects who began the malaria season without P. falciparum infection, incident
P. falciparum infections during the ensuing malaria season were detected prospectively through bi-weekly PCR analysis of fingerprick blood samples. For all
subjects who became infected with P. falciparum blood-stage parasites, incident cases of febrile malaria (axillary temperature ≥37.5 °C and ≥2500 asexual
parasites/μl of blood) were detected prospectively during the ensuing malaria season through weekly physical examination by the study physician and
blood smear microscopy if malaria was suspected
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Fig. 6 NMDS ordination of the Mali samples on the basis of P. falciparum infection status at the end of the 6-month dry season. Samples from
subjects with persistent, asymptomatic P. falciparum infection at the end of the dry season fall into two components PP1 (orange) and PP2
(red); samples from P. falciparum-uninfected subjects fall into two components as well – PN1 (cyan) and PN2 (blue). The mean vector of each
component is labeled with an asterisk in their respective color. The average ages for the groups are 3.2 years (PP1), 13.6 years (PP2), 1.3 years (PN1) and
9.2 years (PN2)
Fig. 7 Mean proportions (Maximum Posterior Estimate) of the twenty most abundant taxa in the two Dirichlet components PP2 (red) and PN2 (blue).
The lower and upper 95 % credible intervals are shown as error bars
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(Additional file 1: Table S8) revealed a statistically sig-
nificant increased risk of P. falciparum infection for
FM2 subjects versus FM1 subjects (hazards ratio = 2.41;
95 % CI: 1.33-4.36, P = 0.0038).
Finally, we examined the relationship between the stool
microbiota composition present before the malaria season
and the prospective risk of developing febrile malaria in
subjects who became infected with P. falciparum blood-
stage parasites during the ensuing malaria season. Again,
for this analysis we only included subjects who were PCR
negative for P. falciparum infection before the malaria sea-
son and then became infected with P. falciparum during
the ensuing malaria season, as detected through bi-weekly
PCR of fingerprick blood samples. Malaria immune
subjects (n = 49) were defined as those whose P. falcip-
arum infections never progressed to febrile, symptom-
atic malaria despite weekly active clinical surveillance;
whereas malaria susceptible subjects (n = 63) were de-
fined as those whose P. falciparum infection progressed
to a febrile malaria episode (T ≥ 37.5 °C and parasite
density ≥ 2500 asexual parasites/μl). On the basis of the
DMM modeling of the microbiota data described
above, the same FM1 and FM2 sample groups had
similar proportions of malaria immune and susceptible
subjects (FM1: 18 immune and 20 susceptible; FM2: 31
immune and 43 susceptible; P = 0.55), suggesting that
gut microbiota composition is not associated with the
risk of febrile malaria once a P. falciparum blood-stage
infection is established. On the basis of the same
Dirichlet sample groups FM1 and FM2, we also gener-
ated Kaplan-Meier plots and performed log-rank ana-
lysis for time to first febrile malaria episode (Fig. 9b).
We found no statistically significant difference between
FM1 and FM2 for time to first febrile malaria episode
using either the case definition for clinical malaria
(T ≥ 37.5 °C and parasite density ≥2500 asexual para-
sites/μl) or the less restrictive definition of fever and
any level of P. falciparum parasitemia.
Discussion
In this study we aimed to describe the composition of the
gut microbiota in an age-stratified rural West African
population that is exposed to intense seasonal P. falcip-
arum transmission. We compared the gut microbiota
composition in this population with studies conducted in
other regions. In an exploratory analysis we also investi-
gated the relationship between the gut microbiota compos-
ition and the prospective risk of P. falciparum infection as
Fig. 8 Mean proportions (Maximum Posterior Estimate) of the twenty most abundant taxa in the two Dirichlet components FM1 (red) and FM2 (blue).
The lower and upper 95 % credible intervals are shown as error bars
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well as the risk of developing febrile malaria once P. falcip-
arum infection is established.
Like studies conducted in other regions (for instance,
[5]) we found that the alpha diversity of the gut micro-
biota increased with age in both males and females. We
found in this cohort that the most dynamic shifts in
microbiota composition occur before the 3–5 years of
age, possibly related to the transition from breast milk to
solid foods [30] and then changes occur more gradually
through adolescence and adulthood. We observed clear
differences between the composition of the gut micro-
biota in this study and that reported in studies con-
ducted in other parts of the world, underscoring the
diversity of gut microbiotas across geographic regions.
Although the non-uniformity of the 16S variable region
that was selected for sequencing across these studies
may have impacted taxa detection [31], several sample
groups shared similar taxa, albeit at different abundance
levels. The relative impact of factors underlying the ob-
served variability in microbiota composition across geo-
graphic regions such as diet, antibiotic exposure, genetics,
and co-infections remains to be determined.
Using a DMM framework we identified two subject
groups with distinct microbiota profiles (FM1 and FM2)
that exhibited statistically significant differences in the pro-
spective risk of P. falciparum infection after accounting for
age and other potential confounders. The gut microbiota of
subjects at lower risk of P. falciparum infection (FM1)
contained a significantly higher proportion of Bifidobacter-
ium and Streptococcus compared to subjects at higher risk
of P. falciparum infection (FM2). This finding raises the
possibility that modulation of the microbiota with pre- and/
or pro-biotic nutritional supplementation that promotes
the growth of commensal organisms like Bifidobacterium,
particularly in the neonatal period [32, 33], may be of bene-
fit in the context of malaria. Importantly, studies indicate
that natural components of human milk stimulate the
growth of Bifidobacterium [34–36]. Clearly, further studies
are needed to understand the potential interactions be-
tween specific components of the microbiota, innate/
adaptive immune responses, and susceptibility to malaria
and other pathogens that commonly affect this population.
Also of potential interest, the gut microbiota of FM1
subjects contained a significantly higher proportion of
the Enterobacteriaceae Escherichia/Shigella compared to
subjects at higher risk of P. falciparum infection (FM2)
(3.2 % versus 0.7 %, respectively) - an intriguing finding
in light of a recent mouse study in which anti-α-gal anti-
bodies induced by the presence of α-gal-expressing Escheri-
chia coli in the gut, were cytotoxic to α-gal-expressing
Plasmodium sporozoites in the skin, thus protecting mice
from Plasmodium infection [25]. Because not all Enterobac-
teriaceae express α-gal [37] we are unable to ascertain from
the present 16S data whether strains in these samples
express α-gal. A functional screen for the expression of this
gene or a metagenomic approach would be required to
Fig. 9 Stool microbiota composition is associated with the prospective risk of P. falciparum infection but not the prospective risk of febrile malaria.
Kaplan-Meier plots showing time to (a) the first PCR-confirmed P. falciparum blood-stage infection (irrespective of whether symptoms were present)
and (b) the first febrile malaria episode among subjects with documented P. falciparum infection, stratified by the two DMM sample groups FM1 and
FM2. P values comparing FM1 to FM2 were calculated by the log-rank test
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answer this question. It will be of interest in future studies
to use higher resolution techniques to determine if differ-
ences in the proportion of α-gal expressing Enterobacteria-
ceae are associated with the risk of P. falciparum infection.
Moreover, additional studies are needed in various malaria-
endemic areas to determine if the findings here can be rep-
licated, since the association we observed between micro-
biota composition and P. falciparum infection risk may
have occurred by chance or may be confounded by other
factors not measured in this study.
Importantly, we did not observe a relationship be-
tween the gut microbiota composition and the prospect-
ive risk of developing febrile malaria once P. falciparum
blood-stage infections were established, possibly due to a
lack of statistical power. However, we observed clear
changes in the microbiota composition over the age
range during which clinical immunity to febrile malaria
is slowly acquired in areas of intense malaria transmis-
sion [20], suggesting that age-associated changes in the
gut microbiota from infancy to adulthood may play a
role in shaping the quality of the immune response to
malaria as individuals gradually acquire clinical immun-
ity to malaria, hypotheses that could be further tested in
larger longitudinal studies.
Conclusions
The findings of this study underscore the diversity of
the gut microbiota with age and across geographic
regions. In addition, the preliminary finding of an
association between gut microbiota composition and P.
falciparum infection risk suggests that strategic modu-
lation of gut microbiota composition could decrease P.
falciparum infection risk in malaria-endemic areas,
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of Health (NIH) and of the J. Craig Venter Institute (JCVI)
approved this study. Written, informed consent was ob-
tained from adult subjects and from the parents or guard-
ians of participating children.
Study site and subjects
This cohort study was conducted in Mali in the rural
village of Kalifabougou which has a population of 4,394
and is situated ~40 km northwest of the capital Bamako.
Bambara is the predominant ethnic group and ~90 % of
residents engage in subsistence farming. Kalifabougou is
in the savanna ecoclimatic zone where annual rainfall is
800–1,200 mm/year. Intense transmission of P. falcip-
arummalaria occurs during the rainy season in this region
of Mali from June through December. In May 2011, we
enrolled 695 healthy individuals aged 3 months to 25 years
in a cohort study to investigate mechanisms of naturally
acquired immunity to malaria using systems biology ap-
proaches. A detailed description of the cohort has been
published elsewhere [38]. As part of the initial clinical
assessment, spleen size was scored using the Hackett
method [39], with splenomegaly defined as a Hackett
score >1. Baseline hemoglobin values, measured by a
HemoCue analyzer, were used to determine anemia
status based on WHO criteria, and hemoglobin typing
was performed with a D-10 instrument (Bio-Rad) to
identify individuals with sickle cell trait (HbAS). Ex-
clusion criteria at enrollment included a hemoglobin
level <7 g/dL, axillary temperature ≥37.5 °C, acute sys-
temic illness, underlying chronic disease, use of anti-
malarial or immunosuppressive medications in the
past 30 days, or pregnancy. As part of a mass drug ad-
ministration program in Mali [40, 41] all residents
greater than 5 years of age received albendazole, iver-
mectin, and praziquantel in March 2011 (prior to en-
rollment) and only albendazole and ivermectin in
October 2011. For the stool microbiota analysis de-
scribed here, we randomly selected an age-stratified
subset of 200 individuals from the entire cohort; the
selection process is shown in Fig. 1.
Surveillance for symptomatic and asymptomatic
Plasmodium infection
After enrollment, individuals were followed during the
ensuing malaria season for 7 months. Symptomatic mal-
aria episodes were detected prospectively by self-referral
and through weekly active clinical surveillance. All indi-
viduals with signs and symptoms of malaria and any
level of Plasmodium parasitemia detected by light mi-
croscopy were treated according to the National Malaria
Control Program guidelines in Mali. Thick blood smears
were stained with Giemsa and counted against 300 leu-
kocytes. Parasite densities were recorded as the number
of asexual parasites/μl of blood based on a mean leukocyte
count of 7500 cells/μl. Each smear was read in a blinded
manner by two certified microscopists. The research def-
inition of clinical malaria was parasitemia of ≥2500 para-
sites/μL, an axillary temperature of ≥37.5 °C within 24 h,
and no other cause of fever discernible by physical exam.
To detect asymptomatic Plasmodium infections during
the 7-month study period, blood was collected by finger-
prick onto filter paper at bi-weekly scheduled visits. At the
end of the study period, stored filter papers were analyzed
by PCR chronologically from enrollment onwards until
the first P. falciparum infection of the malaria season was
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detected for each individual. A detailed description of the
PCR protocol was published elsewhere [20].
Detection of urinary and intestinal parasites
Stool and urine samples were collected at enrollment. S.
haematobium eggs were quantified by microscopy after
filtration of fresh urine samples with Nytrel filters
(Vestergaard Frandsen). Schistosoma mansoni and
other geohelminth eggs were detected by microscopy of
duplicate fresh fecal thick smears using the Kato-Katz
method [42]. Aliquots of stool were cryopreserved at
−80 °C for DNA extraction and multi-parallel, real-time
PCR for intestinal nematodes (Necator americanus,
Ancylostoma duodenale, Trichuris trichiura, Ascaris
lumbricoides, and Strongyloides stercoralis) was per-
formed as previously described [43]. Individuals diag-
nosed with urinary schistosomiasis were treated with
praziquantel (see Table 1).
Stool collection and microbial DNA extraction
The sub-cohort that is the primary focus of this study
was comprised of 200 subjects—106 females and 94
males ranging in age from 3 months to 25 years. Stool
samples were collected at study enrollment in May 2011
just prior to the six-month malaria season. Stool samples
were stored in −80 °C freezers in Mali and shipped to
the U.S. on dry ice for analysis. Microbial DNA for 16S
rDNA gene sequencing was isolated from stool samples
using enzymatic lysis followed by phenol-chloroform isoa-
myl alcohol extraction and ethanol precipitation. Standard
Roche protocols were used for sample preparation.
16S rRNA gene sequencing
The 16S rRNA gene amplicons were quantified and
pooled in equal mass ratios such that amplicons derived
from samples to be analyzed could be multiplexed in a
single Roche-454 sequencing run. Established 454 FLX
sequencing methods (Roche) that were developed for
the HMP, including universal PCR primers with unique
barcode identifiers, were used to amplify and sequence
the hypervariable regions (V1-V3) of the bacterial 16S
rRNA gene [31].
Comparative dataset analysis
16S rRNA gene sequence data generated from stool sam-
ples collected as part of three other studies were included
in the analysis component of this study for comparative
purposes only. These additional studies included a cohort
in Malawi [5], the HMP cohort [44], and the healthy con-
trols from the moderate-to-severe diarrhea (MSD) study
[6]. Data for the Malawi cohort was retrieved from MG-
RAST (http://metagenomics.anl.gov/). The Malawi cohort
was part of accession “mgp401” (http://metagenomics.anl.
gov/linkin.cgi?project=401) [5]. This study sequenced the
V4 region of the 16S rRNA gene using Illumina HiSeq
2000. We were primarily interested in the Malawi cohort
because of similarities in age distribution and geographic
location. Specifically, the Malawi cohort was comprised of
114 subjects ranging in age from 1.5 weeks to 44 years (age
data for 31 subjects were unavailable) and consisted of 63
females and 20 males (gender data for the remaining sub-
jects were unavailable). In common with the present Mali
cohort, sequences from the HMP cohort were derived from
the V1-V3 regions of the stool bacterial 16S rRNA gene
using 454 pyrosequencing. These samples originated from
140 stool samples collected and processed during the
HMP. Raw sequence data and metadata were retrieved
from the HMP Data Analysis and Coordination Center
(HMPDACC) (http://www.hmpdacc.org/). The subjects in
the HMP cohort ranged in age from 18 to 40 years and 73
were females and 67 males. Data for the MSD study were
downloaded from SRA at NCBI and were available under
the bioproject accession PRJNA234437. In the MSD study
sequence data was generated (using 454 FLX sequencing)
from the V1-V2 region of the 16S rRNA gene from DNA
extracted from stool samples. Healthy control samples in
the MSD study were identified from the full data set using
the available study meta-data and only these (493 in total)
were included in the comparison here. The healthy control
samples in the MSD study were collected from individuals
residing in Bangladesh (117), The Gambia (134), Kenya
(140) and Mali (102). These individuals were all under
5 years of age (ranging from 1 to 58 months) and no gen-
der information was available from the study metadata.
16S rRNA sequence data processing
For the 454 data, the raw flowgram files (Standard
Flowgram Format) were deconvolved using the sample
barcode information, and the barcodes and primers
were trimmed subsequently. All processing of the 454
and Illumina sequences from the various studies were
carried out using mothur v1.28 [45] - quality check, se-
quence screening and filtering, chimera checking, and
taxonomy assignment steps used the HMP SOP for 16S
rRNA gene (16S) curation (http://www.hmpdacc.org/
HM16STR/). OTUs at 97 % sequence identity were
computed for the Malian cohort in order to assess sub-
genus diversity and structure. The comparisons of the
present Malian cohort to the other three datasets were
carried out only at the genus level.
For the Malian cohort, from the initial 200 samples,
195 samples were successfully sequenced and each sam-
ple yielded more than 1,000 16S rRNA sequences after
barcode and primer trimming. Together, the samples re-
sulted in 1,500,243 sequences that were used for down-
stream analysis. Reads were aligned against a reference
template, trimmed (keeping only > =100 bp sequences),
and checked for chimeras. The resulting output consisted
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of 1,331,167 sequences. These were assigned taxonomy
down to the genus level using mothur's implementation of
the RDP classifier (using a bootstrap confidence threshold
of 80 %). For OTU analysis, this sequence set was proc-
essed further by alignment column trimming, in which
the required length of trimmed sequences was > =200 bp.
This yielded 968,362 total sequences. These were clus-
tered at 97 % sequence identity to generate OTUs.
Statistical analysis of the 16S data
The taxonomic assignments of the 16S sequences were
used to generate sample-taxa count matrices. These
matrices were analyzed using a DMM modeling frame-
work [28] to identify sample groups, where each sample
group (also known as a Dirichlet component or cluster)
can be summarized by a vector of taxa proportions. The
optimal number of Dirichlet components along with the
mean proportion of each taxa in a Dirichlet component
was calculated using the software developed by Holmes
et al. [28]. The program was run for various values of K,
the number of components, and subsequently, the K
with the best model fit using the Laplace approximation
to the negative log model evidence was chosen as the
optimal value for that dataset. The Dirichlet component
means were calculated from the Maximum Posterior
Estimates (MPE) of the model hyperparameters [28].
Statistical analysis of the clinical data
For continuous variables we compared the differences
between group medians with the Kruskal-Wallis test
(Table 2); for binary variables, group comparisons were
performed using Fisher’s exact test. Kaplan-Meier curves
were used to estimate the probability of remaining free
of clinical malaria. For individuals who began the mal-
aria season PCR-negative for Plasmodium, Kaplan-Meier
curves were also used to estimate the probability of
remaining free of blood-stage P. falciparum infection.
Individuals who were infected with Plasmodium malariae
were censored at the time of infection. Log-rank analysis
was used to test the significance of differences in time to
first febrile malaria episode and time to first P. falciparum
infection between DMM clusters. A Cox proportional
hazards model was used to estimate the risk of P. falcip-
arum infection between DMM clusters and included the
following potentially confounding variables: age (per one
year increase), HbAS, gender, mild anemia at enrollment,
S. haematobium infection, presence of splenomegaly at
enrollment (Hackett score >1) and distance from home to
river (largest stream in Kalifabougou; per 100 m increase).
This combination of variables met the assumptions of
proportional hazards. Of these variables, HbAS has been
shown to affect the risk of P. falciparum infection [46, 47],
and we have evidence to suggest that baseline splenomeg-
aly increases subsequent to P. falciparum infection risk
(unpublished data). Statistical significance was defined as
a 2-tailed P value of <0.05. We performed all analyses in R
version 3.1.1 (http://www.R-project.org).
Availability of supporting data
The data sets supporting the results of this article are
included within the article (and its additional file(s)).
The sequence data for the Malian cohort are available
at NCBI’s Sequence Read Archive under BioProject
PRJNA285808. These data are also available at MG-
RAST under Project 4793.
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Additional file 1: Table S1. Taxonomic composition of Dirichlet
components DC1 and DC2. Table S2. Fit of DMM modeling for various
values of K (the number of Dirichlet components). Best fit is highlighted
in red. Table S3. Taxonomic composition of Dirichlet components CC1
through CC9. Table S4. Distribution of samples from the four cohorts
(Mali, HMP, Malawi, and MSD) in the 9 Dirichlet components (CC1
through CC9). Table S5. Fit of DMM modeling for various values of K
(the number of Dirichlet components) for P. falciparum infection status
analysis. Best fit is highlighted in red. Table S6. Taxonomic composition
of Dirichlet components PP1, PP2, PN1, and PN2. Table S7. Taxonomic
composition of Dirichlet components FM1 and FM2. Table S8. Cox
model of DMM Component: Time to Infection. Figure S1. Increase in
microbial taxa diversity with age in the Malian cohort. For each stool
microbiota sample, the alpha diversity on the y-axis was plotted against
the individual’s age in years (x-axis). The blue lines are the linear model
fits and all of them have positive slope (P < 10−9). Four different alpha
diversity measures are reported (Sobs – the observed #OTUs, Chao estimate,
Ace estimate, and Shannon diversity). Similar trends are observed when the
datasets are analyzed separately by gender. Figure S2. Evaluation of model
fit of Dirichlet mixtures to the Mali dataset. Model fit is evaluated using the
Laplace approximation to the model evidence for varying values of K (the
number of Dirichlet components). For these data, K = 2 results in the best fit.
(ZIP 595 kb)
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